Search Results
Found 33 results
510(k) Data Aggregation
(295 days)
A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.
Tested chemotherapy drugs are as follows:
| Test Chemotherapy drug & Concentration | Average Breakthrough Detection Time (Minutes) |
|---|---|
| Carmustine (BCNU)(3.3 mg/ml) | 12.1 min. |
| Cyclophosphamide (Cytoxan) (20.0 mg/ml) | >240 min. |
| Doxorubicin Hydrichloride (2.0mg/) | >240 min. |
| Etoposide (Toposar) (20.0mg/ml) | >240 min. |
| Fluorouracil (50.0mg/ml) | >240 min. |
| Methotrexate (25.0 mg/ml) | >240 min. |
| Paclitaxel (Taxol) (6.0 mg/ml) | >240 min. |
| Thiotepa(10.0 mg/ml) | 10.1 min. |
| Vincristine Sulfate(1.0 mg/ml) | >240 min. |
| Cisplatin(1.0 mg/ml) | >240 min. |
| Dacarbazine(10 mg/ml) | >240 min. |
| Mitomycin C(0.5 mg/ml) | >240 min. |
Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 12.1 minutes and Thiotepa:10.1 minutes.
Warning: Do not use with Carmustine or Thiotepa
| Fentanyl Citrate & Concentration | Minimum Breakthrough Detection Times |
|---|---|
| Fentanyl Citrate Injection(100 mcg/2ml) | >240 min. |
The Nitrile Patient Examination Gloves with Hyaluronic Acid Blue Colored and Tested for Use with Chemotherapy Drugs and Fentanyl citrate. Aka Synguard C+ Nitrile Exam Gloves are non-sterile, single use only, disposable, powder free examination gloves. The glove is made of nitrile butadiene rubber. Chlorination is applied to the inner surface of the glove to make donning easy. Characteristic:
- Ambidextrous with beaded cuff and straight fingers
- Finger-textured,
- Blue colored
- Containing Hyaluronic Acid coating.
- Six (6) sizes extra-small, small, medium, large, extra-large and XXL.
- Tested against chemotherapy drugs and fentanyl citrate.
The gloves are designed to meets the specifications of ASTM D6319-19, Standard Specification for Nitrile Examination Gloves for Medical Application.
The provided document is a 510(k) summary for a medical device (nitrile patient examination gloves with hyaluronic acid) and details the performance testing against established standards.
Here's a breakdown of the acceptance criteria and study information, based on the provided text:
1. A table of acceptance criteria and the reported device performance:
The document includes a "Technological Characteristics Comparison Table" (pages 7-9) that serves this purpose. It compares the applicant's device to a predicate device (K200671). The "Acceptance Criteria" column effectively outlines the criteria, and the "Anhui Intco Medical Products Co., Ltd. Nitrile Patient Examination Gloves..." column shows the reported device performance.
| Characteristics | Acceptance Criteria (from predicate/standards) | Reported Device Performance (Anhui Intco Medical Products Co., Ltd.) | Comparison Conclusions |
|---|---|---|---|
| Product Code | LZA, LZC, OPJ, QDO | LZA, LZC, OPJ, QDO | (Implicitly "Same") |
| Intended use | A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs as per ASTM D6978-05. | A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. | Same |
| Material used | Nitrile | Nitrile | Identical |
| Color | Blue | Blue | Same |
| Single use | Single Use | Yes | Same |
| Non Sterile | Non Sterile | Non Sterile | Same |
| Other | (Implicit: Additives related to coating) | Hyaluronic Acid coated on the donning surface | Different(1) |
| Dimensions | Overall Length (mm): For XS, S, Min 220mm; For M,L,XL,XXL Min 230mm. Width (± 10mm): XS=70mm, S=80mm, M=95mm, L=110mm, XL=120mm, XXL=130mm. Thickness at Palm (mm) Min: 0.05mm. Thickness at Finger Tip (mm) Min: 0.05mm. | Complies with ASTM D6319-19: X Small 70±10, Small 80 ±10, Medium 95±10, Large 110 ±10, X large 120 ±10, XX Large 130 ±10. Thickness: Palm - 0.05mm min., Finger - 0.05 mm min. | Similar |
| Physical properties | Before Ageing: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 500min. After Aging: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 400min. | Meets ASTM D6319-19: Tensile Strength: Before Aging 14 MPa, min. After Aging 14 MPa, min. Elongation: Before Aging 500% min. After Aging 400% min. | Meets the criteria |
| Freedom from pinholes | AQL 2.5, Inspection Level G-1 | In accordance with ASTM D6319-19 and ASTM D5151-19, G-1, AQL 2.5 | Meets the criteria |
| Residual Powder | Less than 2mg per glove ASTM D 6124-06 | Average powder residue < 2mg per glove | Meets the criteria |
| Primary Skin Irritation Test | ISO10993-10:2010 | Under the conditions of this study, the test article was a non-irritant. | Same |
| Dermal Sensitization Assay | ISO10993-10:2010 | Under the conditions of this study, the test article was a non-sensitizer. | Same |
| Acute systemic toxicity | ISO 10993-11:2017 | Under the conditions of this study, No evidence of acute systemic toxicity | Same |
| Resistance against Chemotherapy Drugs | Standards Practice for Assessment of resistance of Medical Glove to Permeation by Chemotherapy drugs ASTM D6978-05(2013) | 1) Carmustine (BCNU) (3.3 mg/ml), Breakthrough time: 12.1 min.2) Cyclophosphamide (Cytoxan), (20.0 mg/ml), Breakthrough time: >240 min.3) Doxorubicin Hydrochloride (2.0mg/), Breakthrough time: >240 min.4) Etoposide (Toposar) (20.0mg/ml), Breakthrough time: >240 min.5) Fluorouracil (50.0mg/ml), Breakthrough time:>240 min.6) Methotrexate (25.0 mg/ml), Breakthrough time: >240 min.7) Paclitaxel (Taxol) (6.0 mg/ml), Breakthrough time: >240 min.8) Thiotepa, Breakthrough time: 10.1 min.9) Vincristine Sulfate (1.0 mg/ml), Breakthrough time:>240 min.10) Cisplatin (1.0 mg/ml), Breakthrough time:>240 min.11) Dacarbazine (10 mg/ml), Breakthrough time:>240 min.12) Mitomycin C (0.5 mg/ml), Breakthrough time:>240 min.13) Fentanyl Citrate Injection (100 mcg/2ml), Breakthrough time:>240 min. | Similar |
2. Sample size used for the test set and the data provenance:
The document does not explicitly state the sample sizes for the test sets in the non-clinical tests (e.g., how many gloves were tested for pinholes, how many animals were used for biocompatibility testing). However, it refers to industry standards like ASTM and ISO, which typically define appropriate sample sizes for such tests.
- Provenance: The tests were performed in accordance with international standards (ASTM, ISO). The manufacturing company is Anhui Intco Medical Products Co., Ltd. located in Anhui, China. The testing itself is presented as non-clinical testing to demonstrate performance against these standards. The testing format suggests a retrospective evaluation against pre-defined performance criteria.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):
This information is not applicable as the document describes performance testing of physical characteristics of gloves against codified standards (ASTM, ISO), not an AI device or a diagnostic device requiring expert interpretation of results to establish ground truth. The "ground truth" here is the pass/fail criteria defined by the standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
This is not applicable as the document describes performance testing of physical characteristics against codified standards. There is no subjective adjudication process for the test results.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This is not applicable. The device is a medical glove, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
This is not applicable. The device is a medical glove, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
The "ground truth" for the performance tests conducted (e.g., tensile strength, pinholes, chemical permeation, biocompatibility) is established by industry standards and test methods (ASTM D6319-19, ASTM D5151-19, ASTM D6124-06, ASTM D6978-05, ISO 10993 series). These standards define the acceptable range or threshold for a given characteristic to be considered compliant.
8. The sample size for the training set:
This is not applicable. The device is a medical glove, not an AI model that requires a training set.
9. How the ground truth for the training set was established:
This is not applicable.
Ask a specific question about this device
(402 days)
A patient examination glove is a disposable device intended for medical purposes that is worn upon the examiner's hands or fingers to prevent contamination between patient and examiner.
The subject device in this 510(k) Notification is Nitrile Patient Examination Gloves, Powder Free, Pink Color. The subject device is a patient examination glove made from nitrile compound, pink color, powder free and non-sterile (Per 21 CFR 880.6250, class I). These gloves are pink in color and are powder free. The gloves are ambidextrous single use disposable devices that come in six sizes (XS, S, M, L, XL and XXL).
The provided text describes the acceptance criteria and the study results for the "Nitrile Patient Examination Gloves, Powder Free, Pink Color" manufactured by Shandong YINGHONG Medical Products Co., Ltd.
Here's the breakdown of the requested information:
1. A table of acceptance criteria and the reported device performance
| Test Method (Purpose) | Acceptance Criteria | Reported Device Performance (Results) |
|---|---|---|
| Dimensions (length, width, thickness) (ASTM D6319-19) - To evaluate the physical dimension of the glove | Length: 220 mm min (XS, S); 230 mm min (M, L, XL, XXL) | Pass (240 mm min) |
| Width (mm): XS: 70±10; S: 80±10; M: 95±10; L: 110±10; XL: 120±10; XXL: 130±10 | Pass (XS: average 78.4mm; S: average 86.2mm; M: average 97.4mm; L: average 108.7mm; XL: average 115.5mm; XXL: average 123.5mm) | |
| Thickness(mm): Palm: Minimum 0.05; Finger: Minimum 0.05 | Pass (Palm - 0.056mm min.; Finger - 0.082mm min) | |
| Physical properties (ASTM D6319-19) - To evaluate the tensile strength and ultimate elongation before and after aging | Before Aging: Tensile Strength: 14 MPa, min.; Elongation: 500%, min. After Aging: Tensile Strength: 14 MPa, min.; Elongation: 400%, min. | Pass (Before Aging: Tensile Strength: 20.6MPa, min.; Elongation: 531%, min. After Aging: Tensile Strength: 21.9MPa, min.; Elongation: 416%, min.) |
| Freedom from holes (ASTM D5151-19) - To detect holes in the gloves | In accordance with ASTM D6319-19 and ASTM D5151-19, G-1, AQL 2.5 (Implicit in "Similar" comparison to predicate) | (The specific result for this test is not explicitly stated in the table provided for the subject device, but the comparison table indicates "Similar" to the predicate which met these standards) |
| Residual Powder (ASTM D6124-06) - To detect the powder residue in the glove | <2mg per glove | Pass (Average 0.15 mg per glove) |
| In Vitro Cytotoxicity Test (ISO 10993-5) - To determine the cytotoxic potential of the glove. | Under the conditions of the study, the device is not cytotoxic | Pass (Under the conditions of the study, the device have no cytotoxic effect) |
| Skin Sensitization Test (ISO 10993-10) - To determine the skin sensitization potential of the glove. | Under the conditions of the study, the device is not a sensitizer | Pass (Under the conditions of the study, the device is not a sensitizer.) |
| Skin Irritation Test (ISO 10993-10) - To determine the potential of the glove under test to produce irritation. | Under the conditions of the study, the device is not an irritant | Pass (Under the conditions of the study, the device is not an irritant.) |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document primarily discusses non-clinical physical and biocompatibility testing. It cites compliance with ASTM and ISO standards for these tests. For these types of tests, specific sample sizes beyond what the standards prescribe are usually not detailed in the summary. For example, ASTM D6319-19 and ASTM D5151-19 would define the sampling plans. The document mentions "Three Lot" for the residual powder test, suggesting at least three batches were sampled.
The data provenance is from the manufacturer, Shandong YINGHONG Medical Products Co., Ltd., which is located in Qingzhou, Shandong, China. The studies are prospective as they are conducted for the specific purpose of device submission and evaluation against standards.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not applicable as the device is a patient examination glove and the tests performed are physical and biocompatibility evaluations against established industry standards (ASTM, ISO). These do not involve human interpretation or expert-established ground truth in the way medical imaging or diagnostics might. The "ground truth" is defined by the objective measurement specifications of the standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not applicable for the same reasons as point 3. Physical and biocompatibility tests are objective and do not typically involve adjudication.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not applicable. The device is an examination glove, not an AI-assisted diagnostic tool.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
This information is not applicable. The device is an examination glove, not an algorithm.
7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)
The "ground truth" for the performance evaluation of these gloves is based on established industry standards and regulatory specifications as outlined in ASTM D6319-19, ASTM D6124-06, ASTM D5151-19, ISO 10993-10, and ISO 10993-5. This is objective and measurable, rather than relying on expert consensus or pathology in a clinical diagnostic sense.
8. The sample size for the training set
This information is not applicable. There is no "training set" in the context of physical and biocompatibility testing of a medical device like an examination glove. These tests are direct evaluations against performance criteria.
9. How the ground truth for the training set was established
This information is not applicable as there is no training set for this type of device and testing.
Ask a specific question about this device
(114 days)
The Nitrile Patient Examination Glove is a non-sterile disposable device intended for medical purposes that is worn on the examiner's hands or finger to prevent contamination between patient and examiner.
The subject device is powder free nitrile examination gloves. The subject device is blue. The subject device is non-sterile.
This document describes the performance testing for a medical device: "Nitrile Patient Examination Glove" (K222527). The tests demonstrate that the device meets established acceptance criteria, primarily through non-clinical performance testing.
1. A table of acceptance criteria and the reported device performance
| Acceptance Criteria (Standard) | Reported Device Performance (Results) |
|---|---|
| Biocompatibility - Skin Sensitization (ISO 10993-10:2010) | Grades less than 1, otherwise sensitization. |
| Biocompatibility - Skin Irritation (ISO 10993-10:2010) | If the primary irritation index is 0-0.4, the response category is Negligible. 0.5-1.9 means slight, 2-4.9 means moderate, 5-8 means severe. |
| Biocompatibility - Cytotoxicity (ISO 10993-5:2009) | Viability reduced to <70% of the blank indicates cytotoxic potential. |
| Residual Powder Content (ASTM D6124-06 (Reapproved 2017)) | Powder residue limit of 2.0 mg/glove. |
| Freedom from Holes (ASTM D5151-06 (Reapproved 2015)) | Samples number: 125 gloves. AQL: 2.5 (ISO 2859). Criterion ≤7 gloves for water leakage. |
| Dimensions (ASTM D6319-10 (Reapproved 2015)) | Length: S $\ge$ 220 mm; M, L, XL $\ge$ 230 mm. Width (mm): S: 80±10; M: 95±10; L: 110±10; XL: 120±10. Thickness (mm): Finger $\ge$ 0.05; Palm $\ge$ 0.05. |
| Physical Properties - Before Aging (ASTM D6319-10) | Tensile strength: $\ge$ 14 MPa. Ultimate Elongation: $\ge$ 500%. |
| Physical Properties - After Accelerated Aging (ASTM D6319-10) | Tensile strength: $\ge$ 14 MPa. Ultimate Elongation: $\ge$ 400%. |
2. Sample sizes used for the test set and the data provenance
- Freedom from Holes: 125 gloves were tested.
- Biocompatibility (Irritation, Sensitization, Cytotoxicity), Powder Content, Dimensions, Physical Properties: The document does not specify the exact sample size for each of these tests, but it indicates that tests were performed according to the referenced ASTM and ISO standards, which typically include specific sampling plans. For instance, ASTM D6319 for dimensions requires a certain number of gloves per lot for testing.
- Data Provenance: The document does not explicitly state the country of origin for the data or whether it was retrospective or prospective. Given the submitter's address is in China and the nature of the device (examination gloves), it is likely that the testing was conducted by or on behalf of the manufacturer, presumably in adherence to international standards.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This document describes technical and biological performance testing for medical gloves, not an AI or imaging device that requires expert human interpretation for ground truth. Therefore, there were no "experts" in the sense of radiologists or clinicians establishing ground truth for diagnostic accuracy in a test set. The "ground truth" for these tests is defined by the objective measurements obtained through standardized laboratory procedures (e.g., tensile strength, dimensions, chemical analysis, in vitro/in vivo biocompatibility assays).
4. Adjudication method for the test set
Not applicable. As noted above, this device did not involve human interpretation or subjective assessment that would require an adjudication method. The test results are quantitative measurements against predefined criteria.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is not an AI/imaging device, therefore, no MRMC study was conducted.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an AI/imaging device, therefore, no standalone algorithm performance testing was conducted.
7. The type of ground truth used
The ground truth used for these tests is based on:
- Physical Measurements: Objective measurements of dimensions (length, width, thickness), tensile strength, and elongation according to ASTM standards.
- Chemical Analysis: Quantitative measurement of residual powder content.
- Biological Assays: Standardized in vitro (cytotoxicity) and in vivo (irritation, sensitization on animals) biological tests using established protocols (ISO 10993 standards) where the "ground truth" is the observed biological response compared to predefined thresholds.
- Defect Detection: Water leakage test for freedom from holes.
8. The sample size for the training set
Not applicable. This device does not involve machine learning or AI, so there is no training set in the AI context. The manufacturing process for gloves is subject to quality control and batch testing, rather than an AI training and validation paradigm.
9. How the ground truth for the training set was established
Not applicable, as there is no training set.
Ask a specific question about this device
(168 days)
The nitrile examination glove is intended to be worn on the examiner's hand to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.
These gloves were tested for use with chemotherapy drugs per ASTM D6978-05 (2019)Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Tested chemotherapy drugs are as follows: Carboplatin, 10 mg/ml >240 min. Carmustine (BCNU), 3.3 mg/ml 27.5 min Cisplatin, 1.0 mg/ml >240 min Cyclophosphamide (Cytoxan), 20.0 mg/ml >240 min Doxorubicin HCI, 2.0 mg/ml >240 min Etoposide, 20.0 mg/ml >240 min Fluorouracil, 50.0 mg/ml >240 min Paclitaxel, 6.0 mg/ml >240 min Thio Tepa, 10.0 mg/ml 88.2 min
Please note that the following drugs have low permeation times: Carmustine (BCNU) 3.3 mg/ml 27.5 Minutes, Thio Tepa 10.0 mg/ml 88.2 Minutes.
Warning: Please do not use with Carmustine and Thio Tepa.
The proposed device (Mode: NG101) is powder free nitrile examination gloves, provided as non-sterile and disposable device. The proposed devices are blue color and there are five sizes, include XS (6.5"), S (7"), M (8"), L (8.5"), XL (9") for optional. The examination glove is smooth surface with textured fingertips and a rolled rim at the cuff edge. This is a single-use, powder-free, non-sterile device.
The gloves are designed and manufactured in accordance with the ASTM D6319-10 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019)
The document describes the non-clinical testing performed to demonstrate that the Nitrile Patient Examination Gloves (K221747) meet their acceptance criteria and are substantially equivalent to a predicate device (K211220).
1. Table of Acceptance Criteria and Reported Device Performance:
| Test Methodology | Purpose | Acceptance Criteria | Reported Device Performance |
|---|---|---|---|
| ASTM D6319-19 | Physical Dimension | The actual measured dimension of the gloves shall meet the stated tolerance specified in Table 2 of ASTM D6319-19. | Meet the requirement |
| ASTM D6319-19 | Determination of Physical Properties | Before and after accelerated aging, the gloves shall conform to the physical requirements in Table 3 of ASTM 6319-19 (Tensile Strength: Before Aging ≥ 14 MPa, After Aging ≥ 14 MPa. Elongation: Before Aging 500%, After Aging 400%). | Meet the requirement |
| ASTM D5151-19 | Water Leak Test for Detection of Holes | The gloves shall be free from hole when tested in accordance with the method given in ASTM D5151-19, AQL = 2.5. | Meet the requirement |
| ASTM D6124-06(2017) | Residual Powder Content Test | The powder residue content shall be not more than 2mg per glove. | Meet the requirement |
| ISO 10993-5: 2009 | In Vitro Cytotoxicity | The MEM test extract shows no cytotoxic potential to L929 mouse fibroblast cells. | Meet the requirement |
| ISO 10993-10: 2010 | Skin Sensitization | The test article extracts show no evidence of causing delayed dermal contact sensitization in the guinea pig. | Meet the requirement |
| ISO 10993-10: 2010 | Skin Irritation | There is no erythema and no edema observed on the skin of the animals treated with the test extracts. | Meet the requirement |
| ASTM D6978-05 (Chemotherapy Drugs) | Chemotherapy Drugs (Permeation Breakthrough Time) | Carboplatin, 10 mg/ml >240 min.Carmustine (BCNU), 3.3 mg/ml 27.5 minCisplatin, 1.0 mg/ml >240 minCyclophosphamide (Cytoxan), 20.0 mg/ml >240 minDoxorubicin HCl, 2.0 mg/ml >240 minEtoposide, 20.0 mg/ml >240 minFluorouracil, 50.0 mg/ml >240 minPaclitaxel, 6.0 mg/ml >240 minThio Tepa, 10.0 mg/ml 88.2 min | Except for Carmustine and Thio Tepa, acceptance criteria were met. |
2. Sample size used for the test set and the data provenance:
The document does not explicitly state the sample sizes for each specific test within the non-clinical testing. It generally refers to "Final finished product" as the tested sample. The data provenance is not specified, but it can be inferred that the testing was conducted by or on behalf of the manufacturer, Fitone Latex Products Co., Ltd. Guangdong, which is based in China. The nature of the tests (physical, chemical, and biocompatibility) suggests these were laboratory-based tests on manufactured product samples. The document does not indicate if the data is retrospective or prospective, though it is standard practice for such tests to be prospective assessments of newly manufactured products.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not applicable as the tests described are non-clinical, objective measurements against established ASTM and ISO standards for material properties and performance. There is no human interpretation or expert ground truth establishment for these types of tests (e.g., measuring glove dimensions, tensile strength, or chemical permeation).
4. Adjudication method for the test set:
This information is not applicable for the same reason as point 3. Adjudication methods are typically used in studies involving human interpretation or subjective assessments.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This information is not applicable. The submission is for a medical glove, not an AI-powered diagnostic device. Therefore, no MRMC study or AI assistance comparison was conducted.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
This information is not applicable as the device is not an algorithm or AI-based system.
7. The type of ground truth used:
The "ground truth" for the non-clinical tests is based on established industry standards and specifications:
- ASTM D6319-19 (Standard Specification for Nitrile Examination Gloves for Medical Application)
- ASTM D5151-19 (Test Method for Detection of Holes in Medical Gloves)
- ASTM D6124-06(2017) (Test Method for Residual Powder on Medical Gloves)
- ASTM D573-04(2019) (Test Method for Rubber-Deterioration in an Air Oven)
- ISO 10993-5: 2009 (Biological Evaluation Of Medical Devices -- Part 5: Tests For In Vitro Cytotoxicity)
- ISO 10993-10: 2010 (Biological Evaluation Of Medical Devices Part 10: Tests For Irritation And Skin Sensitization)
- ASTM D6978-05 (Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs)
These standards define the acceptance criteria (e.g., minimum tensile strength, maximum residual powder, breakthrough times for chemotherapy drugs).
8. The sample size for the training set:
This information is not applicable as there is no training set for a medical glove. These are physical products tested against predetermined specifications.
9. How the ground truth for the training set was established:
This information is not applicable as there is no training set.
Ask a specific question about this device
(93 days)
The Nitrile Patient Examination Glove is a non-sterile disposable device intended for medical purposes that is worn on the examiner's hands or finger to prevent contamination between patient and examiner.
The subject device is powder free nitrile examination gloves. The subject device is blue. The subject device is non-sterile.
The provided text describes the acceptance criteria and performance of a Nitrile Patient Examination Glove, not an AI-powered medical device. Therefore, the questions related to AI device performance metrics, such as ground truth, expert consensus, MRMC studies, and training/test sets, are not applicable in this context.
This document is a 510(k) Premarket Notification for a Class I medical device (nitrile examination glove), which establishes substantial equivalence to a predicate device based on physical and performance characteristics, and biocompatibility.
Here's a breakdown of the relevant information provided:
1. Acceptance Criteria and Reported Device Performance
The acceptance criteria are primarily based on established ASTM and ISO standards for medical gloves. The reported device performance is compared against these standards and the predicate device.
| Test / Characteristic | Acceptance Criteria (Standard Reference) | Reported Device Performance |
|---|---|---|
| Biocompatibility | ||
| Irritation (ISO 10993-10:2010) | Primary Irritation Index: 0-0.4 (Negligible) | Primary irritation index is 0. Response categorized as negligible. All animals survived with no abnormal signs. |
| Sensitization (ISO 10993-10:2010) | Grades less than 1 (no sensitization) | All grades are 0. Not a sensitizer under study conditions. |
| Cytotoxicity (ISO 10993-5:2009) | Viability (viab.%) of 100% extract ≥ 70% of blank (no cytotoxic potential) | Viab.% of 100% test article extract is 70.9%. No potential toxicity to L-929 in MTT method. |
| Physical Properties | ||
| Residual Powder (ASTM D6124-06) | <0.25 mg/glove (Table 4) or 2.0 mg (Table 5) | <0.25 mg/glove |
| Freedom from Holes (ASTM D5151-19) | AQL=2.5, criterion ≤ 7 gloves for water leakage (Sample size: 125 gloves) | No glove water leakage found. |
| Dimensions (ASTM D6319-19) | Min Length: S (220mm), M, L, XL (230mm) Width: S (80±10mm), M (95±10mm), L (110±10mm), XL (120±10mm) Min Thickness (Finger/Palm): 0.05mm | Length (mm): S: 297-302, M: 296-302, L: 296-302, XL: 297-302 (All meet min length) Width (mm): S: 84-87, M: 94-97, L: 104-108, XL: 113-117 (All meet ±10mm tolerance) Thickness (mm): Finger: 0.152-0.184, Palm: 0.112-0.131 (All meet min 0.05mm) |
| Physical Properties | ||
| Before Aging: Tensile Strength | ≥ 14MPa | 14.2-29.0 MPa |
| Before Aging: Ultimate Elongation | ≥ 500% | 537.700% - 552.733% |
| After Accelerated Aging: Tensile Strength | ≥ 14MPa | 14.1-26.8 MPa |
| After Accelerated Aging: Ultimate Elongation | ≥ 400% | 421.422% - 552.633% |
2. Sample size used for the test set and the data provenance
- Freedom from Holes (ASTM D5151-19): 125 gloves were tested.
- Other tests (Biocompatibility, Dimensions, Physical Properties, Powder Content): Specific sample sizes for each test are not explicitly stated in the provided text, but testing was conducted to meet the requirements of the referenced ASTM and ISO standards, which define appropriate sample sizes and methodologies.
- Data Provenance: Not specified in terms of country of origin for the test data. The manufacturer is Jiangxi Zhonghong Pulin Medical Products Co.,Ltd. in China. The data would be prospective, as it's generated specifically for this regulatory submission.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This is a medical device (glove), not an AI diagnostic tool that requires expert interpretation of images or other data for ground truth establishment. The "ground truth" here is the physical and chemical properties of the glove measured against established engineering and biological standards.
4. Adjudication method for the test set
Not applicable for a medical glove. Testing relies on standardized methods and laboratory measurements, not human adjudication of results in the way AI model outputs are typically adjudicated.
5. If a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was done
Not applicable. MRMC studies are used for diagnostic imaging devices/algorithms to assess how human reader performance is affected by AI assistance. This device is a physical examination glove.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
Not applicable. There is no algorithm to assess.
7. The type of ground truth used
The "ground truth" for this device is based on:
- Standardized Test Methods: Adherence to established international and national standards (e.g., ISO 10993 for biocompatibility, ASTM D6319 for physical properties of gloves, ASTM D5151 for freedom from holes).
- Reference Materials/Controls: For biocompatibility tests, positive and negative controls would be used as part of the standard methodology (ISO 10993).
- Objective Measurements: Laboratory measurements of physical dimensions, tensile strength, elongation, powder content, and visual inspection for holes.
8. The sample size for the training set
Not applicable. This is not an AI/machine learning device that requires a training set.
9. How the ground truth for the training set was established
Not applicable for the same reason as above.
Ask a specific question about this device
(29 days)
The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device.
The Nitrile Patient Examination Gloves Blue Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows:
Bleomycin Sulfate 15 mg/ml >240 min. Busulfan 6 mg/ml >240 min. Carboplatin 10 mg/ml >240 min. Carmustine (BCNU) 3.3 mg/ml 17.2 min. Cisplatin 1.0 mg/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Cytarabine HCI 100 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Daunorubicin 5 mg/mL >240 min. Docetaxel 10.0 mg/ml >240 min Doxorubicin HCI 2.0 mg/ml >240 min. Epirubicin HCI 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fludarabine 25.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Gemcitabine 38 mg/ml>240 min. Idarubicin 1 mg/ml >240 min. Ifosfamide 50.0 mg/ml >240 min. Irinotecan 20.0 mg/ml >240 min. Mechlorethamine HCI 1.0 mg/ml>240 min. Melphalan 5 mg/ml >240 min. Methotrexate 25 mg/ml >240 min. Mitromvcin C. 0.5 mg/ml >240 Mitoxantrone 2.0 mg/ml >240 min. Paclitaxel (Taxol) 6.0 mg/ml >240 min. Rituximab 10.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 13.9min. Trisenox 1.0 mg/ml >240 min. Vincristine Sulfate 1.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes
Warning: Do not use with Carmustine and Thiotepa.
The Nitrile Patient Examination Gloves Blue Violet Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.
The tested chemotherapy drug are as follows: Bleomycin Sulfate 15 mg/ml >240 min. Busulfan 6 mg/ml >240 min. Carboplatin 10 mg/ml >240 min. Carmustine (BCNU) 3.3 mg/ml 65.3 min. Cisplatin 1.0 mg/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Cytarabine HCI 100 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Daunorubicin 5 mg/mL >240 min. Docetaxel 10.0 mg/ml >240 min Doxorubicin HCI 2.0 mg/ml >240 min. Epirubicin HCl 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fludarabine 25.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Gemcitabine 38 mg/ml>240 min. Idarubicin 1 mg/ml >240 min. Ifosfamide 50.0 mg/ml >240 min. Irinotecan 20.0 mg/ml >240 min. Mechlorethamine HCI 1.0 mg/ml>240 min. Melphalan 5 mg/ml >240 min. Methotrexate 25 mg/ml >240 min. Mitromvcin C. 0.5 mg/ml >240 Mitoxantrone 2.0 mg/ml >240 min. Paclitaxel (Taxol) 6.0 mg/ml >240 min. Rituximab 10.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 58.3min. Trisenox 1.0 mg/ml >240 min. Vincristine Sulfate 1.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes
Warning: Do not use with Carmustine and Thiotepa.
The Nitrile Patient Examination Gloves Black Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.
The tested chemotherapy drug are as follows: Carmustine (BCNU) 3.3 mg/ml 49.2 min. Cisplatin 1.0 mq/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Doxorubicin HCI 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes Paclitaxel (Taxol) 6.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 87.1min.
Warning: Do not use with Carmustine and Thiotepa.
Powder-Free Nitrile Examination Gloves (Tested for Use with Chemotherapy Drugs) are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are offered in six sizes, extra-small, medium, large, extralarge, extra-extra-large. Three colors are available for all size, includes blue, blue violet and black.
The gloves are designed and manufactured in accordance with the ASTM D6319-10 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019).
This document describes the premarket notification (510(k)) for Nitrile Patient Examination Gloves, with specific testing for chemotherapy drug permeation. Based on the provided text, the "device" is a physical product (gloves) and not an AI/software device, therefore many of the requested criteria (MRMC study, AI assistance, ground truth establishment, training set, etc.) are not applicable.
Here's the breakdown of the acceptance criteria and the study proving the device meets them, based entirely on the provided text:
Acceptance Criteria and Reported Device Performance
1. Table of Acceptance Criteria and Reported Device Performance:
| Test Methodology | Purpose | Acceptance Criteria | Results |
|---|---|---|---|
| ASTM D6319 (Physical Dimensions) | Physical Dimensions Test | Length:Extra-Small: ≥ 220mmSmall: ≥ 220mmMedium: ≥ 230mmLarge: ≥ 230mmExtra-Large: ≥ 230mmExtra-Extra-Large: ≥ 230mmWidth:Extra-Small: 70±10mmSmall: 80±10mmMedium: 95±10mmLarge: 110±10mmExtra-Large: 120±10mmExtra-Extra-Large: ≥120mmThickness (mm):Finger: ≥0.05Palm: ≥0.08 | Pass |
| ASTM D6319 (Physical Properties) | Physical Properties (Tensile Strength & Elongation) | Before Aging:Tensile Strength: ≥14MPaUltimate Elongation: ≥500%After Aging:Tensile Strength: ≥14MPaUltimate Elongation: ≥500% | Pass |
| ASTM D5151 | Freedom from pinholes | Meet the requirements of ASTM D5151 Test for AQL 2.5 | Pass |
| ASTM D6124 | Powder Residue | Meet the requirements of ASTM D6124 < 2.0mg | Pass |
| ISO 10993-10 | To determine if the finished device material is an irritant | Non-irritating | Under the conditions of the study, not an irritant/ Pass |
| ISO 10993-10 | To determine if the finished device material is a sensitizer | Non-sensitizing | Under conditions of the study, not a sensitizer. / Pass |
| ISO 10993-11 | To determine if the finished device material extracts pose a systemic toxicity concern | Non-acute systemic toxicity | Under conditions of the study, did not show acute systemic toxicity in vivo / Pass |
| ASTM D6978-05 (Reapproved 2019) | Assessment of Medical Gloves to Permeation by Chemotherapy Drugs and Fentanyl Citrate | Nitrile Patient Examination Gloves Blue (Tested Drugs & Permeation Time):- Bleomycin Sulfate 15 mg/ml: >240 min.- Busulfan 6 mg/ml: >240 min.- Carboplatin 10 mg/ml: >240 min.- Carmustine (BCNU) 3.3 mg/ml: 17.2 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Cytarabine HCI 100 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Daunorubicin 5 mg/mL: >240 min.- Docetaxel 10.0 mg/ml: >240 min- Doxorubicin HCI 2.0 mg/ml: >240 min.- Epirubicin HCI 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fludarabine 25.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Gemcitabine 38 mg/ml: >240 min.- Idarubicin 1 mg/ml: >240 min.- Ifosfamide 50.0 mg/ml: >240 min.- Irinotecan 20.0 mg/ml: >240 min.- Mechlorethamine HCI 1.0 mg/ml: >240 min.- Melphalan 5 mg/ml: >240 min.- Methotrexate 25 mg/ml: >240 min.- Mitomycin C. 0.5 mg/ml: >240- Mitoxantrone 2.0 mg/ml: >240 min.- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Rituximab 10.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 13.9 min.- Trisenox 1.0 mg/ml: >240 min.- Vincristine Sulfate 1.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutesWarning: Do not use with Carmustine and Thiotepa.Nitrile Patient Examination Gloves Blue Violet (Tested Drugs & Permeation Time):- Bleomycin Sulfate 15 mg/ml: >240 min.- Busulfan 6 mg/ml: >240 min.- Carboplatin 10 mg/ml: >240 min.- Carmustine (BCNU) 3.3 mg/ml: 65.3 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Cytarabine HCI 100 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Daunorubicin 5 mg/mL: >240 min.- Docetaxel 10.0 mg/ml: >240 min- Doxorubicin HCI 2.0 mg/ml: >240 min.- Epirubicin HCl 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fludarabine 25.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Gemcitabine 38 mg/ml: >240 min.- Idarubicin 1 mg/ml: >240 min.- Ifosfamide 50.0 mg/ml: >240 min.- Irinotecan 20.0 mg/ml: >240 min.- Mechlorethamine HCI 1.0 mg/ml: >240 min.- Melphalan 5 mg/ml: >240 min.- Methotrexate 25 mg/ml: >240 min.- Mitomycin C. 0.5 mg/ml: >240- Mitoxantrone 2.0 mg/ml: >240 min.- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Rituximab 10.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 58.3 min.- Trisenox 1.0 mg/ml: >240 min.- Vincristine Sulfate 1.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutesWarning: Do not use with Carmustine and Thiotepa.Nitrile Patient Examination Gloves Black (Tested Drugs & Permeation Time):- Carmustine (BCNU) 3.3 mg/ml: 49.2 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Doxorubicin HCI 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutes- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 87.1 min.Warning: Do not use with Carmustine and Thiotepa. | The permeation resistance was tested and the break-through times for each listed chemotherapy drug are reported as the "Results" for each glove colored variation. The tables within the document (pages 8-10, and 12-14) explicitly list these times. The general acceptance criterion for these types of tests is generally that the glove provides a minimum specified protection time (e.g., >240 minutes for many drugs, unless a shorter warning is given), and these results are directly reported. The "Pass" in the summary table (page 18) indicates overall compliance with the standard for specific tests. |
2. Sample size used for the test set and the data provenance:
- Sample Size: The document does not specify the exact sample size (number of gloves) used for each individual test (e.g., how many gloves were tested for permeation by each drug). It generally refers to "tests" being performed.
- Data Provenance: The tests were conducted according to established ASTM and ISO standards for medical devices. The manufacturer is "Guang Dong Kingfa Sci. & Tech.Co., Ltd." in China. The data itself is from laboratory testing, not from patient data. The studies are non-clinical (in-vitro, physical/chemical tests).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not Applicable. This is a physical device (medical gloves) and not an AI/software device that requires expert human interpretation or consensus for ground truth establishment. The "ground truth" here is the measured performance of the glove against established physical and chemical standards (e.g., tensile strength, pinhole presence, chemical permeation time).
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not Applicable. As this is not an AI/software device involving human-in-the-loop decisions or human interpretive tasks, no adjudication method for ground truth was used.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not Applicable. This is a physical device, not an AI/software system for medical image analysis or diagnosis.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Not Applicable. This is a physical device, not an algorithm. The device's performance is standalone in that its properties (e.g., permeation resistance) are directly measured.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The "ground truth" for these tests is defined by adherence to published international standards (ASTM D6319, ASTM D5151, ASTM D6124, ISO 10993-10, ISO 10993-11, and particularly ASTM D6978-05 for chemotherapy drug permeation). For the chemotherapy drug permeation specifically, the ground truth is the experimentally determined breakthrough time of the specific chemicals through the glove material under controlled laboratory conditions, as specified by the standard.
8. The sample size for the training set:
- Not Applicable. This is a physical device; there is no 'training set' in the machine learning sense. The manufacturing process and quality control would involve internal testing, but this is not referred to as a "training set" in the context of typical AI/ML device submissions.
9. How the ground truth for the training set was established:
- Not Applicable. As there is no training set for an AI/ML model, this point does not apply.
Ask a specific question about this device
(190 days)
Nitrile Patient Examination Gloves, Powder Free, are intended for medical purposes that are worn on the examiners' hands to prevent contamination between patient and examiner.
The Nitrile Patient Examination Gloves, Powder Free are non-sterile, single use only, disposable, and powder free examination gloves. The glove is made of synthetic nitrile latex compound. The device is ambidextrous and can be worn on either the left or right hand. The device meets ASTM D 6319 - Standard specification for Nitrile Examination Gloves for Medical Application.
This document is a 510(k) Premarket Notification for Nitrile Patient Examination Gloves, Powder Free. It demonstrates the substantial equivalence of the proposed device to a legally marketed predicate device (Primus Nitrile Examination Gloves, K143477).
Here's the breakdown of the acceptance criteria and study information:
1. Table of Acceptance Criteria and Reported Device Performance
Device: Nitrile Patient Examination Gloves, Powder Free (Lalan Rubbers (Pvt) Ltd)
| Characteristic | Acceptance Criteria (Predicate Device / ASTM D6319) | Reported Device Performance (Nitrile Patient Examination Gloves, Powder Free) |
|---|---|---|
| Physical Characteristics: | ASTM D6319 requirements | Meets ASTM D6319 requirements |
| Length | Minimum 230mm | Minimum 240mm |
| Palm width (XS) | $70 \pm 10$ | $\leq 80$ |
| Palm width (S) | $80 \pm 10$ | $85 \pm 5$ |
| Palm width (M) | $95 \pm 10$ | $95 \pm 5$ |
| Palm width (L) | $110 \pm 10$ | $105 \pm 5$ |
| Palm width (XL) | $120 \pm 10$ | $\geq 110$ |
| Thickness (Finger) | Minimum 0.05mm | $0.09 \pm 0.01$mm |
| Thickness (Palm) | Minimum 0.05mm | $0.07 \pm 0.01$mm |
| Thickness (Cuff) | Not explicitly defined (implied by ASTM) | $0.05 \pm 0.01$mm |
| Physical Properties: | ASTM D6319 requirements for tensile strength and ultimate elongation | Meets ASTM D6319 requirements |
| Tensile Strength (Before Aging) | Minimum 14 MPa | Minimum 14 MPa |
| Tensile Strength (After Aging) | Minimum 14 MPa | Minimum 14 MPa |
| Ultimate Elongation (Before Aging) | Minimum 500% | Minimum 500% |
| Ultimate Elongation (After Aging) | Minimum 400% | Minimum 400% |
| Freedom from holes: | ASTM D6319 requirements of GI, AQL 2.5 | Meets ASTM D6319 and ASTM D5151 requirements of AQL 2.5 |
| Powder Residual: | ASTM D6319 requirements; Not more than 2.0mg/glove | Meets applicable requirement for powder free; $\leq$ 2 mg per glove |
| Biocompatibility: | ASTM and ISO standards | - |
| Skin Irritation Test | Not an irritant (Under predicate study conditions) | Under the conditions of the study, not an irritant (ISO10993-23:2021) |
| Skin Sensitization Test | Not a sensitizer (Under predicate study conditions) | Under the conditions of the study, not a sensitizer (ISO 10993-10:2010) |
| In Vitro Cytotoxicity | Not explicitly stated for predicate | Diluted concentrations 12.5% and 6.25% are not cytotoxic. Undiluted extract (100%), diluted concentrations 50% & 25% are cytotoxic. (ISO 10993-5:2009) |
| Acute Systemic Toxicity | Not explicitly stated for predicate | Under the conditions of the study, no evidence of systemic toxicity (ISO 10993-11: 2017) |
| Shelf Life | 3 years | 3 years (EN, 455-4:2009) |
2. Sample size used for the test set and the data provenance
The document specifies that non-clinical tests were conducted to verify that the proposed subject device met all design specifications. The sample sizes for each specific test (e.g., number of gloves for physical testing, number of samples for biocompatibility) are not explicitly provided in this summary document. However, the tests are performed according to recognized international standards (ASTM and ISO), which typically specify appropriate sample sizes and methodologies.
The "data provenance" (country of origin, retrospective/prospective) is not detailed for the test samples, but the tests were performed by Lalan Rubbers (Pvt) Ltd in Sri Lanka, which is the manufacturer. The tests are prospective in nature, as they involve testing newly manufactured devices against established standards.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This device (Nitrile Patient Examination Gloves) does not involve expert interpretation or clinical diagnosis that would require human "ground truth" establishment in the typical sense of AI/clinical decision support systems. The "ground truth" here is objective measurement against established physical and chemical standards (ASTM D6319, ISO 10993 series). Therefore, there were no "experts" establishing a subjective ground truth for a test set in this context. The acceptance criteria are quantitative and based on published standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. As noted above, the "ground truth" is objective measurement against established physical and chemical standards. There is no subjective interpretation requiring adjudication.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a medical glove, not an AI-assisted diagnostic or clinical decision support system that involves human readers interpreting cases.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an algorithm or AI device. The tests performed are for the physical, chemical, and biological properties of the glove itself.
7. The type of ground truth used
The ground truth used for this device's performance evaluation against acceptance criteria is objective measurement against recognized international standards and specifications. Specifically:
- Physical and Dimensional Properties: ASTM D6319 (Standard Specification for Nitrile Examination Gloves for Medical Application)
- Freedom from holes: ASTM D6319 and ASTM D5151 (Standard Test Method for Detection of Holes in Medical Gloves)
- Powder Residual: ASTM D6319 and ASTM D6124 (Standard Test Method for Residual Powder on Medical Gloves)
- Biocompatibility: ISO 10993-10, ISO 10993-23, ISO 10993-11, ISO 10993-5 (Biological evaluation of medical devices for irritation, sensitization, systemic toxicity, and cytotoxicity)
- Shelf Life: EN 455-4:2009 (Medical gloves for single use Part 4: Requirements and testing for shelf life determination)
8. The sample size for the training set
Not applicable. This product is not an AI/machine learning model, so there is no concept of a "training set" in this context. The design and manufacturing process for the gloves are developed based on general engineering and material science principles, and then verified through the non-clinical tests mentioned.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for this device.
Ask a specific question about this device
(217 days)
The blue colored nitrile examination glove is intended to be worn on the hands of examiner's to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Blue Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows: Bleomycin Sulfate 15 mg/ml >240 min., Carboplatin 10 mg/ml >240 min., Carmustine (BCNU) 3.3 mg/ml 17.2 min., Cisplatin 1.0 mg/ml >240 min., Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min., Cytarabine HCI 100 mg/ml >240 min., Dacarbazine (DTIC)10.0 mg/ml >240 min., Daunorubicin 5.0 mg/ml >240 min., Docetaxel 10.0 mg/ml >240 min, Doxorubicin HCI 2.0 mg/ml >240 min., Etoposide (Toposar) 20.0 mg/ml >240 min., Fluorouracil 50.0 mg/ml >240 min., Gemcitabine 38 mg/ml>240 min., Idarubicin 1 mg/ml >240 min., Ifosfamide 50.0 mg/ml >240 min., Irinotecan 20.0 mg/ml >240 min., Mechlorethamine HCI 1.0 mg/ml>240 min., Melphalan 5 mg/ml >240 min., Methotrexate 25 mg/ml >240 min., Mitromycin C. 0.5 mg/ml >240, Mitoxantrone 2.0 mg/ml >240 min., Paclitaxel (Taxol) 6.0 mg/ml >240 min., Thiotepa 10.0 mg/ml 13.9 min., Vincristine Sulfate 1.0 mg/ml >240 min. Warning: Do not use with Carmustine and Thiotepa.
The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Blue Violet Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows: Carmustine (BCNU) 3.3 mg/ml 65.3 min., Cisplatin 1.0 mg/ml >240 min., Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min., Dacarbazine (DTIC)10.0 mg/ml >240 min., Doxorubicin HCI 2.0 mg/ml >240 min., Etoposide (Toposar) 20.0 mg/ml >240 min., Fluorouracil 50.0 mg/ml >240 min., Methotrexate 25 mg/ml >240 min., Paclitaxel (Taxol) 6.0 mg/ml >240 min., Thiotepa 10.0 mg/ml 58.3 min. Warning: Do not use with Carmustine and Thiotepa.
The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Black Colored were tested for use with Fentanyl Citrate per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Fentanyl Citrate 100mcg/2ml >240 minutes.
Power-Free Nitrile Examination Gloves (Tested for Use with Chemotherapy Drugs) are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are offered in six sizes, x-small (6.5"), small (7"), medium (8"), large (8.5"), X-large (9"), XXL (9.5"). Three colors are available for all size, includes blue, blue violet and black. The gloves are designed and manufactured in accordance with the ASTM D6319-19 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019).
The provided document describes the acceptance criteria and study results for "Nitrile Patient Examination Gloves" (various colors) tested for use with chemotherapy drugs or Fentanyl Citrate. This is a medical device, and the evaluation is based on non-clinical performance standards rather than an AI/ML algorithm.
Therefore, many of the requested fields related to AI/ML studies (sample size for test set, data provenance, number of experts, adjudication method, MRMC comparative effectiveness, standalone performance, ground truth for training set, training set size) are not applicable to this submission.
Here's the breakdown of the available information:
1. Table of Acceptance Criteria and Reported Device Performance
| Test Item | Methodology / Standard | Acceptance Criteria | Reported Device Performance |
|---|---|---|---|
| Physical Dimensions | |||
| Palm width | ASTM D3767-03(2020) | XS (70±10mm)S (80±10mm)M (95±10mm)L (110±10mm)XL (120±10mm)XXL (≥ 120mm) | Pass |
| Length | ASTM D3767-03(2020) | XS (220mm min)S (220mm min)M (230mm min)L (230mm min)XL (230mm min)XXL (230mm min) | Pass |
| Thickness | ASTM D3767-03(2020) | Finger: 0.11mmPalm: 0.05mm | Pass |
| Integrity | |||
| Freedom from holes | ASTM D5151-19 | Freedom free holeAQL 2.5 | Pass |
| Physical Properties (before aging) | |||
| Tensile Strength | ASTM D412-16 | ≥ 14Mpa | Pass |
| Ultimate Elongation | ASTM D412-16 | ≥ 500% | Pass |
| Physical Properties (after aging) | |||
| Tensile Strength | ASTM D573-04(2019) | ≥ 14Mpa | Pass |
| Ultimate Elongation | ASTM D573-04(2019) | ≥ 400% | Pass |
| Chemical Content | |||
| Residual Powder Content | ASTM D6124-06(2017) | ≤2mg per glove | Pass |
| Biocompatibility | |||
| Cytotoxicity | ISO 10993-5 | Non-cytotoxic | Under conditions of the study, device extract is cytotoxic. |
| Acute Systemic Toxicity | ISO 10993-11 | Non-acute systemic toxicity | Under conditions of the study, did not show acute systemic toxicity in vivo / Pass |
| Irritation | ISO 10993-10 | Non-irritating | Under the conditions of the study, not an irritant/ Pass |
| Sensitization | ISO 10993-10 | Non-sensitizing | Under conditions of the study, not a sensitizer./ Pass |
| Chemotherapy Drug Permeation | ASTM D6978-05 (Reapproved 2019) | Min. permeation breakthrough time as specified for each drug | Achieved or exceeded specified times for individual drugs (see detailed lists in pages 2, 4, 5, 7, 8, 11, 12). |
| Fentanyl Citrate Permeation | ASTM D6978-05 (Reapproved 2019) | Min. permeation breakthrough time as specified (e.g., >240 min) | Achieved >240 minutes for Fentanyl Citrate (see detailed lists in pages 5, 8, 12). |
2. Sample size used for the test set and the data provenance
- Sample Size: Not explicitly stated for each test, but standard ASTM and ISO methods generally specify sample sizes. For example, AQL 2.5 for "freedom from holes" implies a sampling plan. Since these are performance tests on manufactured goods, the "test set" would be a batch or set of gloves sampled from production.
- Data Provenance: The document does not specify a country of origin for the testing data. The studies are described as "Non clinical tests" performed according to established international standards (ASTM, ISO). They are prospective in the sense that they are performed on the device to be marketed.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- This is not applicable as the "ground truth" for these tests is defined by objective physical and chemical measurements according to standardized protocols (ASTM, ISO), not expert interpretation.
4. Adjudication method for the test set
- Not applicable, as the evaluation is based on objective measurements against defined standards.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
- Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.
7. The type of ground truth used
- The "ground truth" for these tests is the direct measurement of physical properties (e.g., dimensions, tensile strength, elongation), chemical properties (e.g., residual powder content), and barrier properties (permeation breakthrough time for chemotherapy drugs and Fentanyl Citrate) against established, objective industry standards (ASTM, ISO). For biocompatibility, it's the observed biological response to the glove material under controlled test conditions.
8. The sample size for the training set
- Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.
9. How the ground truth for the training set was established
- Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.
Ask a specific question about this device
(87 days)
A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.
The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.
This document describes the safety and performance of Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs) as submitted for FDA 510(k) clearance (K213048). The study focuses exclusively on comprehensive bench testing and biocompatibility assessments, demonstrating the device's adherence to established standards for medical gloves, particularly regarding chemotherapy drug permeation.
1. Table of Acceptance Criteria and Reported Device Performance
| Test Method | Purpose | Acceptance Criteria | Reported Device Performance |
|---|---|---|---|
| ASTM D6319 | Physical Dimensions Test | Length (mm):XS: ≥220;S/M/L/XL/XXL: ≥230Width (mm):XS: 70±10;S: 80±10;M: 95±10;L: 110±10;XL: 120±10;XXL: 130±10Thickness (mm):Finger: ≥0.05;Palm: ≥0.05 | Length (mm):All sizes: > 240/PassWidth (mm):XS: 80-83/PassS: 86-90/PassM: 97-98/PassL: 108-112/PassXL: 115-120/PassXXL: 128-130/PassThickness (mm):Finger: 0.08-0.10/PassPalm: 0.08-0.11/Pass |
| ASTM D5151 | Watertightness Test for Detection of Holes | Meet the requirements of ASTM D5151 AQL 2.5 | 0/125/Pass (This implies that out of 125 samples tested, 0 failed, meeting AQL 2.5) |
| ASTM D6124 | Powder Content | Meet the requirements of ASTM D6124 < 2.0mg | 0.03mg/Pass |
| ASTM D412 | Physical properties (Before Aging) | Tensile Strength: ≥14MPaUltimate Elongation: ≥500% | Tensile Strength: 15.1-16.9MPa/PassUltimate Elongation: 536-559%/Pass |
| ASTM D412 | Physical properties (After Aging) | Tensile Strength: ≥14MPaUltimate Elongation: ≥400% | Tensile Strength: 16.0-18.0MPa/PassUltimate Elongation: 540-553%/Pass |
| ISO 10993-5 | Cytotoxicity | Non- In Vitro Cytotoxicity | Under conditions of the study, device extract is not cytotoxic. /Pass |
| ISO 10993-10 | Irritation | Non-irritating | Under the conditions of the study, not an irritant. / Pass |
| ISO 10993-10 | Sensitization | Non-sensitizing | Under conditions of the study, not a sensitizer. / Pass |
| ASTM D6978-05 (Chemotherapy Drug Permeation) | Assessment of Resistance to Permeation by Chemotherapy Drugs | Breakthrough Detection Time for specific drugs to meet or exceed established benchmarks. The established benchmark is typically >240 minutes for many drugs, but lower times are accepted for certain highly permeable drugs, provided they are clearly labeled with warnings. | Carboplatin: > 240 MinutesCarmustine (BCNU): 26.5 Minutes (Warning advised)Cyclophosphamide: > 240 MinutesDoxorubicin: > 240 MinutesEtoposide: > 240 MinutesFluorouracil: > 240 MinutesMethotrexate: > 240 MinutesPaclitaxel: > 240 MinutesThioTepa: 48.4 Minutes (Warning advised) |
2. Sample Sizes Used for the Test Set and Data Provenance
The document does not explicitly state the specific number of units (gloves) for each test, but it does refer to meeting ASTM standards, which would imply a scientifically sound sampling methodology.
For the Watertightness Test, the results state "0/125/Pass," indicating a sample size of 125 units was tested for holes.
The data provenance is based on non-clinical laboratory testing (bench testing) performed by or for Huayuan Medical Technology (Shangqiu) Co., Ltd. The specific location of testing is not detailed beyond the company's address in Shangqiu City, Henan Province, China. The data would be considered prospective for the purposes of this 510(k) submission, as these tests were conducted to demonstrate compliance for the specific device.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. This submission relies on objective, standardized bench tests (e.g., ASTM, ISO standards) to establish performance. The "ground truth" is defined by the technical specifications and criteria outlined in these industry-recognized standards, rather than expert consensus on subjective data (like image interpretation in AI/clinical studies). No human experts were used to establish ground truth in the context of clinical/radiological assessment. The experts involved would be laboratory technicians and engineers qualified to perform and interpret the specified physical, chemical, and biological tests according to the standards.
4. Adjudication Method for the Test Set
Not applicable. Since the study involves objective bench testing against pre-defined acceptance criteria from international standards (ASTM, ISO), no human adjudication of test results is typically required beyond standard quality control and verification procedures of the testing laboratory.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
No. This K213048 submission is for Nitrile Patient Examination Gloves, which are a physical medical device, not a diagnostic imaging AI system. Therefore, an MRMC comparative effectiveness study, which is relevant for evaluating the impact of AI on human reader performance in diagnostic tasks, was not performed. The study focuses on the physical and chemical properties of the gloves.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study was done
Not applicable. This is not an AI-powered diagnostic device or software. The "performance" being assessed is the physical and chemical resistance of the gloves, which is inherently a standalone performance of the material and manufacturing process under controlled laboratory conditions.
7. The Type of Ground Truth Used
The "ground truth" for this device is established by objective laboratory measurements against pre-defined technical specifications and performance criteria set forth in internationally recognized standards (ASTM D6319, ASTM D5151, ASTM D6124, ASTM D412, ASTM D6978-05, ISO 10993-5, ISO 10993-10). For example, the ground truth for "tensile strength" is a measured force in MPa, which is then compared to an acceptance criterion (e.g., ≥14MPa). For chemotherapy drug permeation, the ground truth is the measured breakthrough time in minutes.
8. The Sample Size for the Training Set
Not applicable. This is a traditional medical device (gloves), not an AI/machine learning model. Therefore, there is no "training set." The manufacturing process for physical gloves does not involve machine learning training.
9. How the Ground Truth for the Training Set was Established
Not applicable, as there is no training set for a physical device like examination gloves.
Ask a specific question about this device
(87 days)
A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.
The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.
The provided document is a 510(k) premarket notification for Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs). It details the device's technical characteristics, intended use, and performance testing results to demonstrate substantial equivalence to a predicate device.
Here's the breakdown of the acceptance criteria and study information:
1. Table of Acceptance Criteria and Reported Device Performance
The core performance evaluation for these gloves relates to their physical properties, freedom from holes, powder content, biocompatibility, and most importantly, resistance to permeation by chemotherapy drugs.
| Test Method | Performance Characteristic | Acceptance Criteria | Reported Device Performance |
|---|---|---|---|
| ASTM D6319 | Physical Dimensions Test | ||
| Length (mm) - XS | ≥220 | > 240/Pass | |
| Length (mm) - S/M/L/XL/XXL | ≥230 | > 240/Pass | |
| Width (mm) - XS | 70 ± 10 | 67-72/Pass | |
| Width (mm) - S | 80 ± 10 | 76-83/Pass | |
| Width (mm) - M | 95 ± 10 | 91-99/Pass | |
| Width (mm) - L | 110 ± 10 | 106-112/Pass | |
| Width (mm) - XL | 120 ± 10 | 116-124/Pass | |
| Width (mm) - XXL | 130 ± 10 | 127-134/Pass | |
| Thickness (mm) - Finger | ≥0.05 | 0.06-0.10/Pass | |
| Thickness (mm) - Palm | ≥0.05 | 0.07-0.10/Pass | |
| ASTM D5151 | Watertightness Test for Detection of Holes | Meet the requirements of ASTM D5151 AQL 2.5 | 0/125/Pass (This implies 0 holes out of 125 gloves tested, meeting or exceeding AQL 2.5) |
| ASTM D6124 | Powder Content | Meet the requirements of ASTM D6124 ≤ 2.0mg | 0.02mg/Pass |
| ASTM D412 | Physical Properties (Tensile Strength & Elongation) | ||
| Before Aging: | |||
| Tensile Strength | ≥14MPa | 16.4-17.8MPa/Pass | |
| Ultimate Elongation | ≥500% | 533-551%/Pass | |
| After Aging: | |||
| Tensile Strength | ≥14MPa | 15.8-16.8MPa/Pass | |
| Ultimate Elongation | ≥400% | 520-554%/Pass | |
| ISO 10993-5 | Biocompatibility - Cytotoxicity | Non- In Vitro Cytotoxicity | Under conditions of the study, device extract is not cytotoxic. /Pass |
| ISO 10993-10 | Biocompatibility - Irritation | Non-irritating | Under the conditions of the study, not an irritant. / Pass |
| ISO 10993-10 | Biocompatibility - Sensitization | Non-sensitizing | Under conditions of the study, not a sensitizer. / Pass |
| **ASTM D6978-05 (Reapproved 2019) ** | Chemotherapy Drug Permeation (Minimum Breakthrough Detection Time) | ||
| Carboplatin (10.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Carmustine (BCNU) (3.3 mg/ml) | N/A (Comparative to predicate) | 35.2 Minutes | |
| Cyclophosphamide (Cytoxan) (20.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Doxorubicin (2.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Etoposide (20.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Fluorouracil (50.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Methotrexate (25.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| Paclitaxel (6.0 mg/ml) | N/A (Comparative to predicate) | > 240 Minutes | |
| ThioTepa (10.0 mg/ml) | N/A (Comparative to predicate) | 76.3 Minutes |
Note on Chemotherapy Permeation Acceptance Criteria: The document primarily presents these as reported values and compares them to the predicate device in Table 1 (pages 6-7). The acceptance criteria for these would implicitly be that the breakthrough times are considered sufficient for safe use, or comparable/better than the predicate for equivalent drugs, with a clear warning for drugs with low permeation times. The "Warning: Please do not use with Carmustine (BCNU) and ThioTepa" indicates that the low breakthrough times for these specific drugs are accepted with a cautionary label, rather than requiring an explicit "minimum time" acceptance criterion for regulatory clearance.
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the total sample size for all tests performed. However, it does provide a specific sample size for one critical test:
- Watertightness Test (ASTM D5151): 125 gloves were tested (indicated by "0/125/Pass").
- For other tests (e.g., physical dimensions, tensile strength, powder content, biocompatibility, chemotherapy permeation), the specific number of gloves or samples tested is not explicitly stated in the provided summary, although the ASTM standards themselves would specify statistical sampling plans.
- Data Provenance: The tests were conducted by the manufacturer, Yunnan Huazhiyuan Medical Technology Co., Ltd. The location is China. The studies are retrospective in the sense that they are conducted on manufactured devices to demonstrate compliance with standards for the 510(k) submission, rather than being part of a prospective clinical trial.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This section is not applicable to this type of device and submission. The "ground truth" for the performance of these medical gloves is established through adherence to recognized international and national standards (ASTM, ISO) for physical properties, chemical resistance, and biocompatibility, as measured by laboratory equipment and procedures, not by expert human interpretation or consensus. No human "experts" are interpreting images or clinical data for this non-diagnostic device.
4. Adjudication Method for the Test Set
This section is not applicable. Adjudication methods like 2+1 or 3+1 are used in clinical studies, particularly in imaging or diagnostic device evaluations where multiple readers interpret data and discrepancies need to be resolved. For laboratory bench testing against physical and chemical standards, there is no human interpretation needing adjudication.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
This section is not applicable. MRMC studies are specific to diagnostic devices, especially those involving image interpretation by multiple human readers, to assess the impact of an AI algorithm on reader performance. This device is a medical glove, a Class I non-diagnostic device, and its performance is evaluated through bench testing against established standards, not human reader studies.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This section is not applicable. This device is not an algorithm or AI-based product. Its performance is entirely standalone in the sense that its physical and chemical properties are measured directly from the device itself.
7. The Type of Ground Truth Used
The "ground truth" for this device's performance is based entirely on laboratory bench testing results measured against predefined acceptance criteria established by recognized international standards (ASTM and ISO).
- Physical properties: Measured dimensions, tensile strength, elongation.
- Freedom from holes: Tested using a water-tightness test.
- Powder content: Measured residual powder.
- Biocompatibility: In vitro cytotoxicity, irritation, and sensitization tests.
- Chemotherapy drug permeation: Measured breakthrough times using specific chemical assays as per ASTM D6978-05.
8. The Sample Size for the Training Set
This section is not applicable. This is a physical medical device, not an AI/ML algorithm that requires a training set. The "training" for the device's manufacturing process would be based on quality control and manufacturing specifications, not a data training set.
9. How the Ground Truth for the Training Set Was Established
This section is not applicable as it pertains to AI/ML devices.
Ask a specific question about this device
Page 1 of 4